Table 2 Detailed distribution of 123I-FP-CIT SPECT indications.
From: Relevance of 123I-FP-CIT SPECT prescriptions for the diagnosis of parkinsonian syndromes
Total N = 723 | |
|---|---|
Inappropriate indication | |
Presence of clinically evident PS | 220 (30.4%) |
No information to justify the request | 33 (4.6%) |
Isolated cognitive-behavioural disorders | 18 (2.5%) |
Uncertain indication | |
Suspicion of isolated PS | 82 (11.3%) |
Tremor | 67 (9.3%) |
Other | 29 (4.0%) |
Relevant indication | |
Clinical doubt about PS | 96 (13.3%) |
Iatrogenic vs degenerative PS | 74 (10.2%) |
ET vs parkinsonian tremor | 46 (6.4%) |
Exploration of dementia | 34 (4.7%) |
Vascular vs degenerative PS | 9 (1.2%) |
Functional vs Degenerative PS | 7 (2.0%) |
PS related to NPH vs degenerative | 4 (0.5%) |
PD of atypical evolution | 4 (0.5%) |
